Gene variations in the cholecystokinin system in patients with panic disorder

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Gene variations in the cholecystokinin system in patients with panic disorder. / Koefoed, Pernille; Woldbye, David P; Hansen, Thomas O; Hansen, Elsebeth S; Knudsen, Gitte M; Bolwig, Tom G; Rehfeld, Jens F; Kofoed, Pernille; Woldbye, David Paul Drucker; Hansen, Thomas O; Hansen, Elsebeth; Knudsen, Gitte M; Bolwig, Tom Gert; Rehfeld, Jens F.

In: Psychiatric Genetics, Vol. 20, No. 2, 01.04.2010, p. 59-64.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Koefoed, P, Woldbye, DP, Hansen, TO, Hansen, ES, Knudsen, GM, Bolwig, TG, Rehfeld, JF, Kofoed, P, Woldbye, DPD, Hansen, TO, Hansen, E, Knudsen, GM, Bolwig, TG & Rehfeld, JF 2010, 'Gene variations in the cholecystokinin system in patients with panic disorder', Psychiatric Genetics, vol. 20, no. 2, pp. 59-64. https://doi.org/10.1097/YPG.0b013e32833511a8, https://doi.org/10.1097/YPG.0b013e32833511a8

APA

Koefoed, P., Woldbye, D. P., Hansen, T. O., Hansen, E. S., Knudsen, G. M., Bolwig, T. G., Rehfeld, J. F., Kofoed, P., Woldbye, D. P. D., Hansen, T. O., Hansen, E., Knudsen, G. M., Bolwig, T. G., & Rehfeld, J. F. (2010). Gene variations in the cholecystokinin system in patients with panic disorder. Psychiatric Genetics, 20(2), 59-64. https://doi.org/10.1097/YPG.0b013e32833511a8, https://doi.org/10.1097/YPG.0b013e32833511a8

Vancouver

Koefoed P, Woldbye DP, Hansen TO, Hansen ES, Knudsen GM, Bolwig TG et al. Gene variations in the cholecystokinin system in patients with panic disorder. Psychiatric Genetics. 2010 Apr 1;20(2):59-64. https://doi.org/10.1097/YPG.0b013e32833511a8, https://doi.org/10.1097/YPG.0b013e32833511a8

Author

Koefoed, Pernille ; Woldbye, David P ; Hansen, Thomas O ; Hansen, Elsebeth S ; Knudsen, Gitte M ; Bolwig, Tom G ; Rehfeld, Jens F ; Kofoed, Pernille ; Woldbye, David Paul Drucker ; Hansen, Thomas O ; Hansen, Elsebeth ; Knudsen, Gitte M ; Bolwig, Tom Gert ; Rehfeld, Jens F. / Gene variations in the cholecystokinin system in patients with panic disorder. In: Psychiatric Genetics. 2010 ; Vol. 20, No. 2. pp. 59-64.

Bibtex

@article{a7789f205c0b11df928f000ea68e967b,
title = "Gene variations in the cholecystokinin system in patients with panic disorder",
abstract = "OBJECTIVES: Panic disorder (PD) is a common psychiatric disease occurring more frequently in women than men. Multiple common and/or rare variants in the genome contribute to the complex etiology of the disorder. The neuropeptide cholecystokinin (CCK) and its receptors (the CCK system) have been suggested to be involved in the pathogenesis of PD. METHODS: We examined the promoter, exon, and exon-intron boundaries of the genes encoding CCK and its receptors (CCKAR and CCKBR) for variations in 187 patients with PD and 277 screened control individuals. Up to 1342 additional healthy population controls were examined for some of the variations. One CCK gene intron variation was analyzed for alternative splicing using an exon-trapping assay. RESULTS: The promoter variant (-36C > T; rs1799923) and an intron 1 polymorphism (IVS1-7C > G; rs754635) in the CCK gene were found to protect against PD (P<0.05). The intron 1 variation did not seem to alter the splicing of the gene. None of the other variations found were associated with PD, but a 2-marker haplotype (rs1800855/rs1800857) in the CCKAR gene protected women against PD (P=0.004). In addition, we found two novel rare missense variations in the CCKBR gene (Lys329Asn and Pro446Leu) in two and one patient, respectively. CONCLUSION: The results suggest that the CCK system may play a role in the pathogenesis of PD, with susceptibility alleles both protecting and contributing to the disease. Both common and rare variants seem to be involved. The involvement of the CCK system may also contribute to the increased prevalence of PD in women.",
author = "Pernille Koefoed and Woldbye, {David P} and Hansen, {Thomas O} and Hansen, {Elsebeth S} and Knudsen, {Gitte M} and Bolwig, {Tom G} and Rehfeld, {Jens F} and Pernille Kofoed and Woldbye, {David Paul Drucker} and Hansen, {Thomas O} and Elsebeth Hansen and Knudsen, {Gitte M} and Bolwig, {Tom Gert} and Rehfeld, {Jens F.}",
year = "2010",
month = apr,
day = "1",
doi = "10.1097/YPG.0b013e32833511a8",
language = "English",
volume = "20",
pages = "59--64",
journal = "Psychiatric Genetics",
issn = "0955-8829",
publisher = "Lippincott Williams & Wilkins",
number = "2",

}

RIS

TY - JOUR

T1 - Gene variations in the cholecystokinin system in patients with panic disorder

AU - Koefoed, Pernille

AU - Woldbye, David P

AU - Hansen, Thomas O

AU - Hansen, Elsebeth S

AU - Knudsen, Gitte M

AU - Bolwig, Tom G

AU - Rehfeld, Jens F

AU - Kofoed, Pernille

AU - Woldbye, David Paul Drucker

AU - Hansen, Thomas O

AU - Hansen, Elsebeth

AU - Knudsen, Gitte M

AU - Bolwig, Tom Gert

AU - Rehfeld, Jens F.

PY - 2010/4/1

Y1 - 2010/4/1

N2 - OBJECTIVES: Panic disorder (PD) is a common psychiatric disease occurring more frequently in women than men. Multiple common and/or rare variants in the genome contribute to the complex etiology of the disorder. The neuropeptide cholecystokinin (CCK) and its receptors (the CCK system) have been suggested to be involved in the pathogenesis of PD. METHODS: We examined the promoter, exon, and exon-intron boundaries of the genes encoding CCK and its receptors (CCKAR and CCKBR) for variations in 187 patients with PD and 277 screened control individuals. Up to 1342 additional healthy population controls were examined for some of the variations. One CCK gene intron variation was analyzed for alternative splicing using an exon-trapping assay. RESULTS: The promoter variant (-36C > T; rs1799923) and an intron 1 polymorphism (IVS1-7C > G; rs754635) in the CCK gene were found to protect against PD (P<0.05). The intron 1 variation did not seem to alter the splicing of the gene. None of the other variations found were associated with PD, but a 2-marker haplotype (rs1800855/rs1800857) in the CCKAR gene protected women against PD (P=0.004). In addition, we found two novel rare missense variations in the CCKBR gene (Lys329Asn and Pro446Leu) in two and one patient, respectively. CONCLUSION: The results suggest that the CCK system may play a role in the pathogenesis of PD, with susceptibility alleles both protecting and contributing to the disease. Both common and rare variants seem to be involved. The involvement of the CCK system may also contribute to the increased prevalence of PD in women.

AB - OBJECTIVES: Panic disorder (PD) is a common psychiatric disease occurring more frequently in women than men. Multiple common and/or rare variants in the genome contribute to the complex etiology of the disorder. The neuropeptide cholecystokinin (CCK) and its receptors (the CCK system) have been suggested to be involved in the pathogenesis of PD. METHODS: We examined the promoter, exon, and exon-intron boundaries of the genes encoding CCK and its receptors (CCKAR and CCKBR) for variations in 187 patients with PD and 277 screened control individuals. Up to 1342 additional healthy population controls were examined for some of the variations. One CCK gene intron variation was analyzed for alternative splicing using an exon-trapping assay. RESULTS: The promoter variant (-36C > T; rs1799923) and an intron 1 polymorphism (IVS1-7C > G; rs754635) in the CCK gene were found to protect against PD (P<0.05). The intron 1 variation did not seem to alter the splicing of the gene. None of the other variations found were associated with PD, but a 2-marker haplotype (rs1800855/rs1800857) in the CCKAR gene protected women against PD (P=0.004). In addition, we found two novel rare missense variations in the CCKBR gene (Lys329Asn and Pro446Leu) in two and one patient, respectively. CONCLUSION: The results suggest that the CCK system may play a role in the pathogenesis of PD, with susceptibility alleles both protecting and contributing to the disease. Both common and rare variants seem to be involved. The involvement of the CCK system may also contribute to the increased prevalence of PD in women.

U2 - 10.1097/YPG.0b013e32833511a8

DO - 10.1097/YPG.0b013e32833511a8

M3 - Journal article

C2 - 20023595

VL - 20

SP - 59

EP - 64

JO - Psychiatric Genetics

JF - Psychiatric Genetics

SN - 0955-8829

IS - 2

ER -

ID: 19662627